Advanced Search

Healthcare Products Stocks List

Symbol Grade Name % Change
NTUS A Natus Medical Incorporated 0.73
NVS A Novartis AG 0.87
SNY A Sanofi 2.53
TXMD A TherapeuticsMD, Inc. 36.56
WAT A Waters Corporation -1.51
TAK A Takeda Pharmaceutical Company Limited 0.96
GPC A Genuine Parts Company -2.62
ABC A AmerisourceBergen Corporation (Holding Co) 0.54
FDUS A Fidus Investment Corporation -2.23
PBH A Prestige Brand Holdings, Inc. 1.41
View As Page of Charts
Related Industries: Asset Management Business Equipment Computer Systems Contract Manufacturers Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services Insurance Brokers Medical Devices Medical Distribution Pharmaceutical Retailers Specialty Retail
Related Stock Lists: Biotechnology Disease Eye Pharmaceutical Pharmacy S&P 500 Acid Animal Health Beverage Cancer Clinic Healthcare Providers Life Sciences Pharmaceutical Products Abrasives Active Pharmaceutical Ingredients Acute Care Hospitals Aerospace Antacid Antibiotics

Related ETFs - A few ETFs which own one or more of the above listed Healthcare Products stocks.

Symbol Grade Name Weight
PPH A Market Vectors Pharmaceutical ETF 19.23
SPBC F Simplify U.S. Equity PLUS GBTC ETF 9.44
IDNA B iShares Genomics Immunology and Healthcare ETF 6.35
PID A PowerShares Intl Dividend Achievers 5.87
VIRS F Pacer BioThreat Strategy ETF 5.76
View all Healthcare Products ETFs...
Compare ETFs
Compare PPH to PID Compare PPH to VIRS Compare SPBC to IDNA

Healthcare Products Stocks Recent News

Date Stock Title
May 20 SNY Sanofi Receives Another Approval for Blockbuster Drug Dupixent
May 20 SNY FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule
May 20 SNY Sanofi wins FDA label expansion for Dupixent for new inflammatory condition
May 20 SNY Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
May 20 SNY FDA Approves Dupixent® (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis
May 20 SNY UPDATE 2-Sanofi's Dupixent wins U.S. approval for bigger use
May 20 TXMD Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump
May 20 TXMD Why TherapeuticsMD Shares Are Trading Higher Today
May 20 TXMD TherapeuticsMD surges 25% on sNDA approval for Annovera birth control ring
May 20 TXMD Mid-Morning Market Update: Markets Open Higher; Deere Tops Q2 Views
May 20 TXMD TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®
May 20 NVS Novartis' Cosentyx gets EMA panel nod for expanded use in certain types of arthritis
May 20 NVS Novartis Cosentyx® (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions
May 20 SNY The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20 SNY This Safe Stock Is Dirt Cheap -- and It's Beating the Market
May 20 SNY Sanofi gets EMA panel nod for enzyme replacement therapy Xenpozyme
May 20 NVS Novartis offers leukemia drug nilotinib to cancer coalition focused on low-income countries' access to drugs - Reuters
May 20 NVS Cancer coalition aims to boost access to medicines in poorer countries
May 19 NVS Alnylam's (ALNY) Marketed Drugs Aid Growth Amid Competition
May 19 TAK The Petri Dish: Taiho acquires Cullinan cancer subsidiary in $405M deal
Related Industries: Asset Management Business Equipment Computer Systems Contract Manufacturers Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services Insurance Brokers Medical Devices Medical Distribution Pharmaceutical Retailers Specialty Retail
Related Stock Lists: Biotechnology Disease Eye Pharmaceutical Pharmacy S&P 500 Acid Animal Health Beverage Cancer Clinic Healthcare Providers Life Sciences Pharmaceutical Products Abrasives Active Pharmaceutical Ingredients Acute Care Hospitals Aerospace Antacid Antibiotics

Browse All Tags